Key Highlights

  • IPO of 7,500,000 Class A shares priced at $10.00 each generated $75,000,000 in gross proceeds.
  • Private placement of 275,000 shares at $10.00 each added $2,750,000 to the capital pool.
  • Underwriter’s deferred commission totals $2,250,000, held within the trust account.

Research Alliance Corp IV (NASDAQ: RACD) announced the successful conclusion of its public offering and a concurrent private placement on July 14 2026. The private placement saw the sponsor acquire an additional 275,000 shares at the same price, contributing $2,750,000 in cash. Together, the transactions supplied the company with the capital necessary to advance its strategic objectives.

IPO Summary

The offering comprised 7,500,000 Class A ordinary shares sold at $10.00 per share, delivering $75,000,000 in gross proceeds. The pricing reflected the market’s assessment of the company’s prospects within its target sector, which includes technology‑enabled services and innovative business solutions.

Private Placement Details

Simultaneously, the sponsor purchased 275,000 shares at $10.00 each, providing an extra $2,750,000. These securities carry registration rights and are subject to limited transfer restrictions until the company consummates its first business combination.

Proceed Allocation

All $75,000,000 derived from the public offering, together with the private placement proceeds, were deposited into a trust account administered by Continental Stock Transfer & Trust Company. The trust is designed to protect public shareholders while the board seeks a suitable acquisition target.

Board Appointments

On the day of the offering, Alan Musso and John Maslowski were added to the board of directors. Musso assumed the chair of the audit committee, whereas Maslowski was appointed to lead both the nominating and compensation committees. These B shares differ from the publicly traded Class A shares but grant the holders voting influence within the company.

Regulatory Milestones

The Securities and Exchange Commission approved the registration statement filed under file number 333- 296609, effective on July 10 2026.

Underwriter and Deferred Compensation

The underwriting agreement includes a deferred commission of $2,250,000, which will be retained in the trust account pending the closing of the business combination.

Future Outlook

With $75,000,000 secured in trust and an additional $2,750,000 from the private placement, Research Alliance Corp IV is well positioned to identify and complete its inaugural business combination. The recent board appointments and share structure adjustments underscore a focus on strong governance and the readiness to execute its growth strategy.

This article is for informational purposes only and does not constitute financial advice. Please consult a licensed financial adviser before making investment decisions.